FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2493678388> ?p ?o ?g. }

• W2493678388 endingPage "867" @default.
• W2493678388 startingPage "860" @default.
• W2493678388 abstract "Brentuximab vedotin (BV) significantly improved progression-free survival in a phase 3 study in patients with relapsed or refractory Hodgkin lymphoma (RR-HL) post-autologous-haematopoietic stem cell transplant (auto-HSCT); we report the impact of BV on quality of life (QOL) from this trial. The European Quality of Life five dimensions questionnaire was administered at the beginning of each cycle, end of treatment, and every 3 months during follow-up; index value scores were calculated using the time trade-off (TTO) method for UK-weighted value sets. Questionnaire adherence during the trial was 87·5% (N = 329). In an intent-to-treat analysis, compared with placebo, TTO scores in the BV arm did not exceed the minimally important difference (MID) of 0·08 except at month 15 (−0·084; 95% confidence interval, −0·143 to −0·025). On-treatment index scores were similar between arms and did not reach the MID at any time point; mixed-effect modelling showed that BV treatment effect was not significant (P = 0·2127). BV-associated peripheral neuropathy did not meaningfully impact QOL. Utility scores for patients who progressed declined compared with those who did not; TTO scores between these patients exceeded the MID beginning at month 15. In conclusion, QOL decreased modestly with BV consolidation treatment in patients with RR-HL at high risk of relapse after auto-HSCT." @default.
• W2493678388 created "2016-08-23" @default.
• W2493678388 creator A5001102192 @default.
• W2493678388 creator A5011398209 @default.
• W2493678388 creator A5013177563 @default.
• W2493678388 creator A5015046564 @default.
• W2493678388 creator A5037707751 @default.
• W2493678388 creator A5046985026 @default.
• W2493678388 creator A5050118503 @default.
• W2493678388 creator A5052032114 @default.
• W2493678388 creator A5055027283 @default.
• W2493678388 creator A5056728544 @default.
• W2493678388 creator A5059149637 @default.
• W2493678388 creator A5066752218 @default.
• W2493678388 creator A5067778266 @default.
• W2493678388 creator A5072154632 @default.
• W2493678388 creator A5078900537 @default.
• W2493678388 creator A5087934925 @default.
• W2493678388 creator A5087990801 @default.
• W2493678388 date "2016-09-21" @default.
• W2493678388 modified "2023-10-02" @default.
• W2493678388 title "Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma" @default.
• W2493678388 cites W1529342185 @default.
• W2493678388 cites W1969771214 @default.
• W2493678388 cites W1980320803 @default.
• W2493678388 cites W1987148708 @default.
• W2493678388 cites W2003504608 @default.
• W2493678388 cites W2062486240 @default.
• W2493678388 cites W2071686284 @default.
• W2493678388 cites W2098428600 @default.
• W2493678388 cites W2100106580 @default.
• W2493678388 cites W2106294189 @default.
• W2493678388 cites W2109300198 @default.
• W2493678388 cites W2119799189 @default.
• W2493678388 cites W2123825357 @default.
• W2493678388 cites W2148775441 @default.
• W2493678388 cites W2316159879 @default.
• W2493678388 cites W2473786944 @default.
• W2493678388 cites W2537593493 @default.
• W2493678388 cites W4245503015 @default.
• W2493678388 doi "https://doi.org/10.1111/bjh.14316" @default.
• W2493678388 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5621593" @default.
• W2493678388 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27649689" @default.
• W2493678388 hasPublicationYear "2016" @default.
• W2493678388 type Work @default.
• W2493678388 sameAs 2493678388 @default.
• W2493678388 citedByCount "23" @default.
• W2493678388 countsByYear W24936783882017 @default.
• W2493678388 countsByYear W24936783882018 @default.
• W2493678388 countsByYear W24936783882020 @default.
• W2493678388 countsByYear W24936783882021 @default.
• W2493678388 countsByYear W24936783882022 @default.
• W2493678388 countsByYear W24936783882023 @default.
• W2493678388 crossrefType "journal-article" @default.
• W2493678388 hasAuthorship W2493678388A5001102192 @default.
• W2493678388 hasAuthorship W2493678388A5011398209 @default.
• W2493678388 hasAuthorship W2493678388A5013177563 @default.
• W2493678388 hasAuthorship W2493678388A5015046564 @default.
• W2493678388 hasAuthorship W2493678388A5037707751 @default.
• W2493678388 hasAuthorship W2493678388A5046985026 @default.
• W2493678388 hasAuthorship W2493678388A5050118503 @default.
• W2493678388 hasAuthorship W2493678388A5052032114 @default.
• W2493678388 hasAuthorship W2493678388A5055027283 @default.
• W2493678388 hasAuthorship W2493678388A5056728544 @default.
• W2493678388 hasAuthorship W2493678388A5059149637 @default.
• W2493678388 hasAuthorship W2493678388A5066752218 @default.
• W2493678388 hasAuthorship W2493678388A5067778266 @default.
• W2493678388 hasAuthorship W2493678388A5072154632 @default.
• W2493678388 hasAuthorship W2493678388A5078900537 @default.
• W2493678388 hasAuthorship W2493678388A5087934925 @default.
• W2493678388 hasAuthorship W2493678388A5087990801 @default.
• W2493678388 hasBestOaLocation W24936783881 @default.
• W2493678388 hasConcept C109159458 @default.
• W2493678388 hasConcept C126322002 @default.
• W2493678388 hasConcept C141071460 @default.
• W2493678388 hasConcept C142724271 @default.
• W2493678388 hasConcept C143998085 @default.
• W2493678388 hasConcept C159110408 @default.
• W2493678388 hasConcept C204787440 @default.
• W2493678388 hasConcept C27081682 @default.
• W2493678388 hasConcept C2778191690 @default.
• W2493678388 hasConcept C2779338263 @default.
• W2493678388 hasConcept C2779951463 @default.
• W2493678388 hasConcept C28328180 @default.
• W2493678388 hasConcept C2992779791 @default.
• W2493678388 hasConcept C44249647 @default.
• W2493678388 hasConcept C54355233 @default.
• W2493678388 hasConcept C71924100 @default.
• W2493678388 hasConcept C86803240 @default.
• W2493678388 hasConceptScore W2493678388C109159458 @default.
• W2493678388 hasConceptScore W2493678388C126322002 @default.
• W2493678388 hasConceptScore W2493678388C141071460 @default.
• W2493678388 hasConceptScore W2493678388C142724271 @default.
• W2493678388 hasConceptScore W2493678388C143998085 @default.
• W2493678388 hasConceptScore W2493678388C159110408 @default.
• W2493678388 hasConceptScore W2493678388C204787440 @default.
• W2493678388 hasConceptScore W2493678388C27081682 @default.
• W2493678388 hasConceptScore W2493678388C2778191690 @default.

• next